TY  - JOUR
A1  - Rovituso, Damiano M.
A1  - Scheffler, Laura
A1  - Wunsch, Marie
A1  - Kleinschnitz, Christoph
A1  - Dörck, Sebastian
A1  - Ulzheimer, Jochen
A1  - Bayas, Antonios
A1  - Steinman, Lawrence
A1  - Ergün, Süleyman
A1  - Kuerten, Stefanie
T1  - CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
T2  - Scientific Reports
N2  - B cell aggregates in the central nervous system (CNS) have been associated with rapid disease progression in patients with multiple sclerosis (MS). Here we demonstrate a key role of carcinoembryogenic antigen-related cell adhesion molecule1 (CEACAM1) in B cell aggregate formation in MS patients and a B cell-dependent mouse model of MS. CEACAM1 expression was increased on peripheral blood B cells and CEACAM1\(^+\) B cells were present in brain infiltrates of MS patients. Administration of the anti-CEACAM1 antibody T84.1 was efficient in blocking aggregation of B cells derived from MS patients. Along these lines, application of the monoclonal anti-CEACAM1 antibody mCC1 was able to inhibit CNS B cell aggregate formation and significantly attenuated established MS-like disease in mice in the absence of any adverse effects. CEACAM1 was co-expressed with the regulator molecule T cell immunoglobulin and mucin domain −3 (TIM-3) on B cells, a novel molecule that has recently been described to induce anergy in T cells. Interestingly, elevated coexpression on B cells coincided with an autoreactive T helper cell phenotype in MS patients. Overall, these data identify CEACAM1 as a clinically highly interesting target in MS pathogenesis and open new therapeutic avenues for the treatment of the disease.
KW  - autoimmunity
KW  - multiple sclerosis
KW  - neuroimmunology
Y1  - 2016
UR  - https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/14769
UR  - https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-147690
VL  - 6
ER  -